Xcell Therapeutics Inc.

373110 KRX Pharmaceuticals Pharmaceuticals
KOSDAQ

Shareholding pattern

As reported to FSS/DART, 2025-12-31.

Largest shareholder group11.76%
Minority shareholders73.86%
Top 10 holders11.76%
Total shareholders33,158

Who owns the company

Share of shares outstanding
Minority shareholders: 73.86%Institutions & other holders: 14.38%Largest shareholder & related parties: 11.76%73.9%Minority shareholders
Minority shareholders 73.86%Institutions & other holders 14.38%Largest shareholder & related parties 11.76%

How to read this: the largest shareholder group is the controlling owner and related parties — a big slice means tight control. Minority shareholders are the many small holders. The remainder is mostly institutional and foreign money, which the regulator does not itemise separately.

Ownership detail

Investor categoryHolding %Shareholders
Minority shareholders73.86%33,148
Institutions & other holders14.38%
Largest shareholder & related parties11.76%

How to read this: a high foreign or institutional share often means the stock is widely researched and more liquid; a high individual share means retail investors hold most of the company. Percentages are of voting units.

Largest shareholders

S.No.ShareholderSharesStake %
1이의일2,019,31611.68%
2이주연14,0000.08%

Trust banks such as Master Trust and Custody Bank appear at the top of most Japanese registers: they hold shares on behalf of many underlying funds rather than owning them outright.

Educational data only. Not a recommendation to buy, sell or hold any security.